Derived from early stem cell research, new treatments may introduce regenerative factors to rejuvenate currently ailing retinal cells without requiring true stem cell transplantation.
The first retinal prosthesis to gain FDA approval is the ARGUS II Retinal Prosthesis System. Though currently it has limited uses, it brings great hope to those with severe retinal disease.
Eylea (aflibercept) is now available for macular degeneration and central retinal vein occlusion. Further use in diabetics is likely to follow soon. Results are impressive.
Concerned about your genetic risk for macular degeneration? Testing is available at The Retina Institute.
For diabetics, regular follow up and treatment by retinal eye doctors are proven to save vision.
High blood pressure (Hypertension) can cause serious vision loss: baseline blood pressure as well as spiking blood pressures from stress or sleep apnea can contribute to vision loss.
Floaters and flashes can signal retinal detachments.
Blurry vision can be much more than a need for glasses. A retinal exam by Dr. Ebrahim can rule out or treat true eye disease.